However, genetic data suggest that complement may be more than bystanders of AD: among the risk variants for AD are CLU, also known as complement lysis inhibitor or APOJ, and CR1, which encodes for the complement component C3b receptor66. This evidence concerns the gene CLU and Alzheimer disease.